North America protein supplement market is expected to grow by 6.42% annually in the forecast period and reach $4,161.6 million by 2026 owing to rising consumer awareness, growing number of fitness centers, and desire to lead active and healthy lifestyles amid COVID-19 pandemic. Highlighted with 35 tables and 56 figures, this 115-page report “North America Protein Supplement Market 2020-2026 by Product Type, Source, Form, Customer Gender, Age Group, Application, Distribution Channel, a...
Europe protein supplement market accounted for $1,466.3 million in 2019 and will grow by 5.98% annually over 2020-2026 owing to rising consumer awareness, growing number of fitness centers, and desire to lead active and healthy lifestyles amid COVID-19 pandemic. Highlighted with 45 tables and 60 figures, this 126-page report “Europe Protein Supplement Market 2020-2026 by Product Type, Source, Form, Customer Gender, Age Group, Application, Distribution Channel, and Country: COVID-19 Imp...
Asia Pacific protein supplement market will grow by 10.18% annually with a total addressable market cap of $10.87 billion over 2020-2026 owing to rising consumer awareness, growing number of fitness centers, and desire to lead active and healthy lifestyles amid COVID-19 pandemic. Highlighted with 42 tables and 59 figures, this 124-page report “Asia Pacific Protein Supplement Market 2020-2026 by Product Type, Source, Form, Customer Gender, Age Group, Application, Distribution Channel, a...
Global clinical nutrition market will reach $77.54 billion by 2026, growing by 6.64% annually over 2020-2026 driven by increasing incidence of malnutrition, the rising prevalence of communicable and non-communicable chronic diseases amid COVID-19 pandemic. Highlighted with 87 tables and 102 figures, this 184-page report “Global Clinical Nutrition Market 2020-2026 by Substrate, Administration Route (Oral or Enteral, Parenteral), End User, Therapeutic Area, Healthcare Setting, Distributio...
North America clinical nutrition market is expected to grow by 5.52% annually in the forecast period and reach $20.39 billion by 2026 driven by increasing incidence of malnutrition, the rising prevalence of communicable and non-communicable chronic diseases amid COVID-19 pandemic. Highlighted with 28 tables and 66 figures, this 124-page report “North America Clinical Nutrition Market 2020-2026 by Substrate, Administration Route (Oral or Enteral, Parenteral), End User, Therapeutic Area, ...
Europe clinical nutrition market accounted for $10.92 billion in 2019 and will grow by 5.89% annually over 2020-2026 driven by increasing incidence of malnutrition, the rising prevalence of communicable and non-communicable chronic diseases amid COVID-19 pandemic. Highlighted with 38 tables and 70 figures, this 130-page report “Europe Clinical Nutrition Market 2020-2026 by Substrate, Administration Route (Oral or Enteral, Parenteral), End User, Therapeutic Area, Healthcare Setting, Dist...
Asia Pacific clinical nutrition market will grow by 8.27% annually with a total addressable market cap of $180.67 billion over 2020-2026 driven by increasing incidence of malnutrition, the rising prevalence of communicable and non-communicable chronic diseases amid COVID-19 pandemic. Highlighted with 35 tables and 69 figures, this 129-page report “Asia Pacific Clinical Nutrition Market 2020-2026 by Substrate, Administration Route (Oral or Enteral, Parenteral), End User, Therapeutic Area...
Global pharmaceutical contract manufacturing market will reach $184.8 billion by 2030, growing by 6.2% annually over 2020-2030 driven by increasing dependence on contract manufacturing organizations due to improved efficiency and productivity amid COVID-19 pandemic. Highlighted with 87 tables and 85 figures, this 173-page report “Global Pharmaceutical Contract Manufacturing Market 2020-2030 by Category, Product (API, FDF), Phase (Clinical, Commercial), Type (Sterile, Non-Sterile), Thera...
North America pharmaceutical contract manufacturing market is expected to grow by 5.4% annually in the forecast period and reach $62.8 billion by 2030 driven by rising need for medicines amid COVID-19 pandemic and increasing dependence on contract manufacturing organizations due to improved efficiency and productivity. Highlighted with 28 tables and 49 figures, this 110-page report “North America Pharmaceutical Contract Manufacturing Market 2020-2030 by Category, Product (API, FDF), Pha...
Europe pharmaceutical contract manufacturing market accounted for $24.4 billion in 2019 and will grow by 6.0% annually over 2020-2030 owing to the rising need for medicines amid COVID-19 pandemic and increasing dependence on contract manufacturing organizations due to improved efficiency and productivity. Highlighted with 38 tables and 53 figures, this 116-page report “Europe Pharmaceutical Contract Manufacturing Market 2020-2030 by Category, Product (API, FDF), Phase (Clinical, Commerc...